Patient Capital Management’s Cleveland-Cliffs CLF Stock Holding History

Patient Capital Management’s Portfolio CLF Stock Details CLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,027,036	Closed	-$21M	–	43
2023 Q4	$21M	Sell	1,027,036 -254,658	-20%	-$4.36M	1.11%	34
2023 Q3	$20M	Sell	1,281,694 -709,613	-36%	-$11.1M	1.18%	33
2023 Q2	$33.4M	Buy	1,991,307 +1,732,982	+671%	+$27.5M	1.86%	29
2023 Q1	$4.74M	Sell	258,325 -21,275	-8%	-$421K	2.11%	27
2022 Q4	$4.5M	Sell	279,600 -87,600	-24%	-$1.32M	2.19%	24
2022 Q3	$4.95M	Hold	367,200	–	–	2.47%	18
2022 Q2	$5.64M	Buy	367,200 +71,500	+24%	+$1.71M	2.5%	17
2022 Q1	$9.52M	Buy	+295,700	New	+$6.74M	3.23%	10

Other funds holding CLF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Patient Capital Management's CLF Position: Q1 2024 in Review

Patient Capital Management sold out of Cleveland-Cliffs (CLF) in Q1 2024, closing a stake of 1,027,036 shares — an estimated $21M sold.

Patient Capital Management first reported a position in CLF in Q1 2022 and held it in 8 quarters. The position peaked at $33.4M in Q2 2023. 637 funds tracked by Wall St. Rank hold CLF as of Q1 2024.

Patient Capital Management reported no remaining Cleveland-Cliffs position as of Q1 2024 after selling out during the quarter.
Patient Capital Management sold 1,027,036 Cleveland-Cliffs shares in Q1 2024, an estimated $21M.
Patient Capital Management first reported a position in Cleveland-Cliffs in Q1 2022 and held it in 8 quarters.
Patient Capital Management's Cleveland-Cliffs position peaked at $33.4M in Q2 2023.
637 funds tracked by Wall St. Rank held Cleveland-Cliffs as of Q1 2024.

Based on Patient Capital Management's 13F filing for Q1 2024, filed 15 May 2024.